Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2010 | 12-2009 | 09-2009 | 06-2009 | 03-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40 | 750 | 270 | 380 | 370 |
| Marketable Securities | 0 | 0 | 800 | 1,050 | 2,290 |
| Receivables | 0 | 140 | 390 | 0 | 0 |
| Other current assets | 1,440 | 1,490 | 1,120 | 1,160 | 900 |
| TOTAL | $1,480 | $2,380 | $2,580 | $2,590 | $3,560 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 4,487 | 4,297 | 4,527 | 4,517 | 4,367 |
| TOTAL | $4,487 | $4,297 | $4,527 | $4,517 | $4,367 |
| Total Assets | $5,980 | $6,690 | $7,130 | $7,120 | $7,940 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,400 | 990 | 420 | 970 | 470 |
| Accrued Expenses | 620 | 450 | 560 | 350 | 500 |
| TOTAL | $4,300 | $1,500 | $980 | $1,330 | $970 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,490 | 970 | 1,430 | 116 | 112 |
| TOTAL | $1,490 | $970 | $1,430 | $116 | $112 |
| Total Liabilities | $5,800 | $2,470 | $2,430 | $1,450 | $1,090 |
| Shareholders' Equity | |||||
| Common Shares | 330 | 280 | 240 | 190 | 190 |
| Retained earnings | -38,390 | -33,110 | -31,400 | -35,950 | -34,360 |
| Other shareholders' equity | 0 | 0 | 0 | 10 | 0 |
| TOTAL | $180 | $4,210 | $4,700 | $5,660 | $6,850 |
| Total Liabilities And Equity | $5,980 | $6,680 | $7,130 | $7,110 | $7,940 |